2 reports

  • ITALY: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015-2022 (USD MILLION)
  • 10.3 EUROPE

Around ##% of Italian biotechnology companies are active in the sectors of genomics, proteomics, and enabling technologies.

  • Cancer
  • Genomics Proteomics And Enabling Technology
  • United States
  • Market Size
  • Roche Group
  • LIST OF ABBREVIATIONS
  • 10.3 EUROPE

AROUND ##% OF THE BIOTECHNOLOGY COMPANIES IN ITALY ARE ACTIVE IN THE SECTORS OF GENOMICS, PROTEOMICS, AND ENABLING TECHNOLOGIES (GPET).

  • Genomics Proteomics And Enabling Technology
  • Proteomics
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.